Comprehensive pan-cancer analysis reveals LAMA5 as a prognostic biomarker associated with tumor immunity in human cancers, with experimental validation in uveal melanoma
Frontiers in Oncology · 17.11.2026 · 16
DOI: 10.3389/fonc.2026.1989435 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 17.11.2026. Verfasst von Yang Liu und 3 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background LAMA5, encoding the laminin α5 chain, is a crucial component of the extracellular matrix implicated in cell adhesion, migration, and signaling. However, a systematic assessment of its pan-cancer prognostic and immunological roles remains elusive.
Methods
We conducted an integrative multi-omics analysis utilizing datasets from TCGA, GTEx, CPTAC, and cBioPortal to evaluate the expression landscape, genetic alterations, diagnostic and prognostic value, and association with tumor immunity of LAMA5 across 33 cancer types. Functional enrichment and pathway analyses were performed to decipher potential mechanisms. Correlations with immune cell infiltration, immunomodulator genes, and chemotherapeutic response were assessed. The biological functions of LAMA5 were further experimentally validated in uveal melanoma (UVM) cell lines through knockdown experiments.
Results
LAMA5 expression was dysregulated across multiple cancer types and was associated with clinicopathological features and survival outcomes in selected cancers, including UVM. Exploratory ROC analyses suggested tissue-level discriminatory potential in several cancers, particularly cholangiocarcinoma. LAMA5 expression was also associated with angiogenesis-, epithelial–mesenchymal transition-, inflammation-, and immune-related transcriptional features. Drug-response and CMap analyses identified exploratory pharmacological associations with LAMA5-related expression patterns. In vitro , LAMA5 knockdown significantly reduced the proliferative, migratory, and invasive capacities of UVM cells.
Conclusion
Our comprehensive pan-cancer study identifies LAMA5 as a prognostic biomarker associated with tumor progression and distinct immune microenvironment features across cancers. Functional experiments in UVM cells further support a tumor cell-intrinsic role for LAMA5 in proliferation, migration, and invasion. These findings highlight the biological and prognostic relevance of LAMA5 in UVM, while its therapeutic potential and possible immunoregulatory functions require further experimental validation.
Zitieren
APA
Liu, Y., Rossmiller, B., Zhang, F., & Fan, W. (2026). Comprehensive pan-cancer analysis reveals LAMA5 as a prognostic biomarker associated with tumor immunity in human cancers, with experimental validation in uveal melanoma. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1989435
Vancouver
Liu Y, Rossmiller B, Zhang F, Fan W. Comprehensive pan-cancer analysis reveals LAMA5 as a prognostic biomarker associated with tumor immunity in human cancers, with experimental validation in uveal melanoma. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1989435
BibTeX
@article{Liu2026,
author = {Liu, Yang and Rossmiller, Brian and Zhang, FangXia and Fan, WenYan},
title = {Comprehensive pan-cancer analysis reveals LAMA5 as a prognostic biomarker associated with tumor immunity in human cancers, with experimental validation in uveal melanoma},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1989435}
}
EUVIMED